Approach to the History and Evaluation of Vertigo and Dizziness - Part 1
In part 1 of a 3 part series, Terry D. Fife, MD, FAAN, FANS discusses his article, "Approach to the History and Evaluation of Vertigo and Dizziness" from the April Neuro-otology Continuum issue. This ...
5 Touko 20212min
NINDS Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome
Dr. Douglas Katz discusses the Neurology Journal article, "National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome". Show references...
4 Touko 20213min
Payment Trends for Neurologist-Prescribed Drugs in Medicare Part D
Dr. Adam de Havenon discusses the Neurology Journal article, "Five-Year Trends in Payments for Neurologist-Prescribed Drugs in Medicare Part D". Show references: https://n.neurology.org/content/96/16/...
3 Touko 20213min
CGRP Inhibitor Use for Migraine and Exacerbation of Raynaud Phenomenon
Dr. Ilana Breen discusses her abstract, "Calcitonin Gene-Related Peptide Inhibitor Use for Migraine Associated with Exacerbation of Raynaud Phenomenon". You can view her abstract and others here: http...
2 Touko 20213min
Safety and Efficacy of the Telestroke Drip-and-Stay Model
Dr. Hena Waseem discusses her abstract, "Safety and Efficacy of the Telestroke Drip-and-Stay Model: A systematic review and meta-analysis". You can view her abstract and others here: https://index.mir...
1 Touko 20213min
Medical Research Funding
In part 2 of a 2-part series, Derek Brandt, Director, Congressional Affairs at the American Academy of Neurology, shares about funding for medical research in the U.S.
30 Huhti 20213min
Veterans Affairs Centers of Excellence
In part 1 of a 2-part series, Derek Brandt, Director, Congressional Affairs at the American Academy of Neurology, shares about the Veterans Affairs Centers of Excellence.
29 Huhti 20212min
Johnson & Johnson COVID-19 Vaccination
Dr. Peter Marks discusses the Johnson & Johnson COVID-19 vaccine.
28 Huhti 20211min
